Last update 21 Dec 2024
Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)
Last update 21 Dec 2024
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingIND Application |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC35H48ClN3O10S |
InChIKeyANZJBCHSOXCCRQ-FKUXLPTCSA-N |
CAS Registry139504-50-0 |
Related
1
Clinical Trials associated with Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)注射用重组抗HER2人源化单克隆抗体在转移性乳腺癌患者中连续给药的多中心药动学和安全性Ⅰb期临床研究
[Translation] A multicenter phase Ib clinical study on the pharmacokinetics and safety of a recombinant anti-HER2 humanized monoclonal antibody for injection in patients with metastatic breast cancer after continuous administration
100 Clinical Results associated with Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant anti-HER2 humanized monoclonal antibody-DM1(Qilu Pharmaceutical Co., Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | IND Application | CN | 21 Jul 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free